When we assessed if healthy monocytes, treated with a CLL-conditioned medium, modulated RANK, RANKL and CD16, we observed that all these molecules were up-regulated and CD16 to a greater extent. The gene discussed is TNFRSF11A; the disease is B-cell chronic lymphocytic leukemia.